肺血动力学和右心功能在高空或低空运动期间在患有肺血管疾病的患者:一个随机交叉试验
Julian Müller1,2, Laura Mayer1, Simon Raphael Schneider1
1Department of Pulmonology, University Hospital Zurich, Zürich, Switzerland.
Heart (British Cardiac Society)
|May 22, 2025
概括
在肺动脉高血压 (PAH) 或慢性血栓栓塞性肺高血压 (CTEPH) 患者中,高海拔不会加剧运动压力. 肺血液动力学和右心功能在高空和低空运动期间保持相似.
科学领域:
- 心肺血管生理学 心肺血管生理学
- 高空医学是一种高度医学.
- 心血管研究的心血管研究.
背景情况:
- 患有肺动脉高血压 (PAH) 或慢性血栓栓塞性肺高血压 (CTEPH) 的患者在高海拔地区可能面临生理挑战.
- 了解海拔高度对这些患者的影响对于管理他们的健康和安全至关重要.
- 这项研究调查了高海拔对PAH/CTEPH患者心肺血液动力学和右心功能的影响.
研究的目的:
- 为了比较PAH/CTEPH患者在高空 (2500米) 和低空 (470米) 运动期间的肺血液动力学和右心功能.
- 在增量和恒定工作率运动测试中评估高度对缩性肺动脉压 (sPAP) 和右心室 (RV) 动脉合的影响.
- 为了确定短期高空暴露是否会在稳定的PAH/CTEPH患者中加剧心肺应激.
主要方法:
- 一项随机交叉试验,涉及27名稳定的PAH/CTEPH患者,没有休息低氧症.
- 患者进行了增量运动测试 (IET) 和恒定工作速率运动测试 (CWRET) 在2500米和470米的高度.
- 心声图用于评估缩性肺动脉压 (sPAP) 和右心室 (RV) 动脉合 (sPAP/tricuspid环状平面缩外流).
主要成果:
- 在高海拔地区,静止时的sPAP更高 (14 mm Hg差异),而RV动脉合则减少 (-0.13 mm/mm Hg差异).
- 在运动期间,sPAP线性增加,在两个高度都有类似的斜率 (7.9 mm Hg/min对比9.7 mm Hg/min).
- 在运动期间,RV动脉合相对减少,在高海拔地区,氧气输送减少.
结论:
- 尽管在高海拔地区休息时的sPAP更高,RV合减少,但运动引起的血液动力学变化在不同高度之间是相似的.
- 在稳定的PAH/CTEPH患者中,短期高空暴露似乎不会在运动期间加剧心肺应激.
- 运动方案的类型 (IET与CWRET) 对血液动力学轨迹的影响比高度本身更大.
相关概念视频
Pulmonary Function Tests
758
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
758
Cardiac Catheterization II: Right Heart Catheterization
845
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
845
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
589
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
589
Pulmonary Hypertension: Classification and Pathogenesis
584
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
584


